IMPACT OF PROPHYLAXIS AGAINST CMV ON HOSPITAL READMISSION RATE FOR ADULT CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC HPT: EXPERIENCE OF THE LETERMOVIR PHASE 3 TRIAL P. Yuste, S. Mt-Isa, C. Badshah, V Teal,R. Leavitt, J. SchelfhoutHAEMATOLOGICA（2019）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
